The expression of chemokine receptors CCR6, CXCR2 and CXCR4 is not organ-specific for distant metastasis in colorectal cancer: A comparative study

Histopathology

Volumn 63, Issue 2, 2013, Pages 167-173

  Hu, Dongzhi ^a   Du, Changzheng ^b   Xue, Weicheng ^b   Dou, Fangyuan ^b   Yao, Yunfeng ^b   Gu, Jin ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Chemokine; Colorectal cancer; Immunohistochemistry; Metastasis; Surgery

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR4;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LUNG METASTASIS; MALE; MEDICAL RECORD REVIEW; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY;

EID: 84880707215     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12127     Document Type: Article

References (24)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J. Clin. 2012; 62; 10-29.
2. Zeelenberg IS, Ruuls-Van SL, Roos E. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res. 2003; 63; 3833-3839.
3. Wagsater D, Dimberg J. Expression of chemokine receptor CXCR6 in human colorectal adenocarcinomas. Anticancer Res. 2004; 24; 3711-3714.
4. Kim J, Takeuchi H, Lam ST et al. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J. Clin. Oncol. 2005; 23; 2744-2753.
5. Schimanski CC, Schwald S, Simiantonaki N et al. Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer. Clin. Cancer Res. 2005; 11; 1743-1750.
6. Ghadjar P, Rubie C, Aebersold DM, Keilholz U. The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer. Int. J. Cancer 2009; 125; 741-745.
7. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000; 12; 121-127.
8. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 2006; 354; 610-621.
9. Gunther K, Leier J, Henning G et al. Prediction of lymph node metastasis in colorectal carcinoma by expression of chemokine receptor CCR7. Int. J. Cancer 2005; 116; 726-733.
10. Cambien B, Karimdjee BF, Richard-Fiardo P et al. Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism. Br. J. Cancer 2009; 100; 1755-1764.
11. Ghadjar P, Coupland SE, Na IK et al. Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer. J. Clin. Oncol. 2006; 24; 1910-1916.
12. Mongan JP, Fadul CE, Cole BF et al. Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines. Clin. Colorectal Cancer 2009; 8; 100-105.
13. Ding Y, Shimada Y, Maeda M et al. Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma. Clin. Cancer Res. 2003; 9; 3406-3412.
14. Fulton AM. The chemokine receptors CXCR4 and CXCR3 in cancer. Curr. Oncol. Rep. 2009; 11; 125-131.
15. Kawada K, Hosogi H, Sonoshita M et al. Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes. Oncogene 2007; 26; 4679-4688.
16. Shimizu Y, Murata H, Kashii Y et al. CC-chemokine receptor 6 and its ligand macrophage inflammatory protein 3alpha might be involved in the amplification of local necroinflammatory response in the liver. Hepatology 2001; 34; 311-319.
17. Rubie C, Oliveira V, Kempf K et al. Involvement of chemokine receptor CCR6 in colorectal cancer metastasis. Tumour Biol. 2006; 27; 166-174.
18. Thorley AJ, Goldstraw P, Young A, Tetley TD. Primary human alveolar type II epithelial cell CCL20 (macrophage inflammatory protein-3alpha)-induced dendritic cell migration. Am. J. Respir. Cell Mol. Biol. 2005; 32; 262-267.
19. Facco M, Baesso I, Miorin M et al. Expression and role of CCR6/CCL20 chemokine axis in pulmonary sarcoidosis. J. Leukoc. Biol. 2007; 82; 946-955.
20. Bracke KR, D'Hulst AI, Maes T et al. Cigarette smoke-induced pulmonary inflammation and emphysema are attenuated in CCR6-deficient mice. J. Immunol. 2006; 177; 4350-4359.
21. Zhu YM, Woll PJ. Mitogenic effects of interleukin-8/CXCL8 on cancer cells. Future Oncol. 2005; 1; 699-704.
22. Ottaiano A, Franco R, Aiello Talamanca A et al. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients. Clin. Cancer Res. 2006; 12; 2795-2803.
23. Li JK, Yu L, Shen Y, Zhou LS, Wang YC, Zhang JH. Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro. World J. Gastroenterol. 2008; 14; 2308-2313.
24. Varney ML, Singh S, Li A, Mayer-Ezell R, Bond R, Singh RK. Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases. Cancer Lett. 2011; 300; 180-188.